Presatovir

DB12165InvestigationalSmall molecule

Presatovir has been used in trials studying the treatment of RSV Infection, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections, and Respiratory Syncytial Virus (RSV) Infections.

Mechanism: Pharmacologically active on Fusion glycoprotein F0
Curator reviewed
Formula / weight: C₂₄H₃₀ClN₇O₃S · 532.06 g/mol (avg)
Code names: GS-5806

Resolves to

Compound

UNII9628AJ27JACAS1353625-73-6ChEMBLCHEMBL3410450PubChem58029842

Structure

InChIKeyGOFXWTVKPWJNGD-UWJYYQICSA-NSMILESCC1=CN2N=C(C=C2N=C1N1CC[C@H](N)C1)[C@@H]1CCCCN1C(=O)C1=CC(Cl)=CC=C1NS(C)(=O)=O

Targets

P03420F

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Presatovir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account